
    
      In-stent restenosis was a series of complications of treatment in peripheral artery disease,
      which lead the fluid of lower extremity re-limited even chronic limb ischemia and amputation.
      Its typical symptoms were recurrent claudication, rest pain and ischemic. Tosaka III in-stent
      restenosis, which also called in-stent occlusion was one of the most serious of this kind of
      complications. Its symptoms usually more severe and irreversible, and its treatments were
      complicated and challenging. The efficacy of single balloon angioplasty is limited. New
      devices including drug-coated balloon, intravascular Lithotripsy, directional atherectomy,
      laser debulking devices and stent-grafts offer another chance and better prognosis. The data
      of these new devices, however, are mainly from low-quality evidence. Therefore, we start this
      prospective, multicenter, real-world, observational study, providing new data on the safety,
      efficacy and health economics evaluation of endovascular treatments for Tosaka III in-stent
      restenosis.
    
  